Sierra White

7PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersFluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Jul 09, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Nov 28, 2024
Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Feb 14, 2024
GPX3 supports ovarian cancer tumor progression <i>in vivo</i> and promotes expression of GDF15.

Caroline Chang, Ya-Yun Cheng, Shriya Kamlapurkar

Pageof 2